• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

AAP opposes school-based drug testing of adolescents

byMikhaela MontyandCordelia Ross
March 30, 2015
in Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The American Academy of Pediatrics (AAP) opposes the use of in-school drug testing as a means to reduce substance abuse among adolescents due to the lack of supportive evidence for its efficacy.

2. The AAP endorses pediatrician advocacy of, and research and resource allocation to, the implementation of effective school-based substance abuse prevention and rehabilitation programs.

Rundown: School-based drug testing programs are a controversial means for substance abuse prevention among teens. Some studies have found decreased use of substances that were tested for in the screening panel, such as marijuana. However, the same studies also point out that the most commonly used drug among teens, alcohol, was not tested. Participation in these studies was voluntary and, as such, students with more serious or consistent substance abuse problems could have simply not elected to participate. Some argue that implementation of this policy will increase truancy and school dropout rates in an effort to avoid being tested. No scientific studies have been conducted comparing this policy to one in which guidance counselors educate students as a means of both prevention and referral to treatment, Given the current dearth of scientific data on this policy, as well as dubious efficacy, negative social consequences, and the potential for breach of confidentiality, the AAP advises against the use of school-based drug testing of adolescents. The AAP encourages pediatricians to advocate for school-based substance abuse programs as well as for the study of their efficacy as a means to confront teenage substance abuse. The AAP strongly supports the establishment of in-school substance abuse programs to prevent drug abuse among teens and to refer those in need of additional services.

Click to read the policy statement, published today in Pediatrics

Relevant Reading: Random student drug testing as a school-based drug prevention strategy

Image: CC

RELATED REPORTS

Samsung BioLogics lands $1.3 billion U.S. contract amid tariff uncertainty

Corstasis’ Enbumyst nasal spray approved for edema

2MM: AI Roundup –Dermatology accuracy, faster drug discovery, heart disease detection, and global medical training [September 11th, 2025]

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adolescent medicinedrugsteens
Previous Post

Menopause linked to decreased anti-HIV activity

Next Post

Motivational interviewing and dietary counseling reduce BMI

RelatedReports

Adalimumab use results in high clinical response rate in hidradenitis suppurativa
All Specialties

Samsung BioLogics lands $1.3 billion U.S. contract amid tariff uncertainty

September 23, 2025
Variation noted across pre- and post-marketing studies for FDA approved devices
Pharma

Corstasis’ Enbumyst nasal spray approved for edema

September 18, 2025
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup –Dermatology accuracy, faster drug discovery, heart disease detection, and global medical training [September 11th, 2025]

September 25, 2025
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Pharma

Drugmakers Increase Prices on Over 250 Medications

May 21, 2025
Next Post
Motivational interviewing and dietary counseling reduce BMI

Motivational interviewing and dietary counseling reduce BMI

Clinic intervention reduces pregnancy risk behaviors in vulnerable youth

USPSTF finds inconclusive evidence for routine iron screening and supplementation in pregnancy

Standardized measures effectively tracked psoriasis and acne outcomes

Hyperkalemia rare among healthy women taking spironolactone for acne

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy
  • Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma
  • Artificial intelligence designed drugs Hit 90% Phase I success rate in trials
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.